Brief Report

Page 2

Recently published articles about Brief Report

PCC
Camptocormia and Antipsychotic Medications
Brief Report

May 23, 2024

Camptocormia, or “bent spine syndrome,” is an often-overlooked adverse effect of antipsychotics; early diagnosis and treatment is essential to prevent severe consequences.
Rashmi Subhedar, Malathi L. Perugula, Kaushal Shah, et al
PCC
Emerging Trends in Opioid Use Disorder Management
Brief Report

April 2, 2024

This report examines trends in opioid use disorder and associated ED visits from 2016 to 2021 and evaluates buprenorphine and naloxone prescribing patterns within these visits.
Abid Rizvi, Christina L. Nolte, Paramjit Chumber, et al
PCC
Brief Cognitive Screener Detects Early Signs of Cognitive Decline in Anglo and Hispanic Patients
Brief Report

December 12, 2023

The South Florida Cognitive Screener is an 8-item self-report instrument developed to capture the most common cognitive, functional, and behavioral complaints typically reported early in the process of cognitive...
Rafael A. Rivas-Vazquez, Gustavo Rey, Alan Quintana, et al
PCC
Benzodiazepines Prescribed With and Without Opioids
Brief Report

December 5, 2023

This study analyzed the National Ambulatory Medical Care Survey to calculate recent changes in rates of benzodiazepine prescription after the release of the CDC guidelines for prescribing opioids for...
Abid Rizvi, Deep Yadava, Sadia Rehman Safwi
JCP
Pimavanserin for Insomnia in Veterans With PTSD
Brief Report

November 6, 2023

Patients in this pilot study reported significantly improved sleep quality with pimavanserin.
Melissa B. Jones, Ritwick Agrawal, Amir Sharafkhaneh, et al
PCC
Benzodiazepines Prescribed With and Without Opioids
Brief Report

October 3, 2023

Thirty percent of prescription opioid overdose deaths involve benzodiazepines. This study analyzed ED visits with benzodiazepines prescribed at discharge, with and without opioids.
Abid Rizvi, Deep Yadava, Christina Nolte
PCC
Therapeutic Approaches for Long COVID Neuropsychiatric Sequelae
Brief Report

October 3, 2023

While the literature on therapeutic agents for long COVID is limited, several psychopharmacologic options have shown potential in managing its neuropsychiatric sequelae.
Samuel Reinfeld, Michael La Sala
JCP
Dual Orexin Receptor Antagonists and Suicide Risk
Brief Report

September 27, 2023

According to the WHO pharmacovigilance database, suicidal behavior was 1.3 times more frequent than expected with dual orexin receptor antagonists and 4.7 times more frequent for Z-drugs; data on...
Francesco Salvo, Laura Palagini, Pierre A. Geoffroy
PCC
Perceived Stress Associated With COVID-19 in Neuro-Behcet’s Disease
Brief Report

September 5, 2023

The COVID-19 pandemic has affected the lives of healthy individuals as well as people with chronic diseases due to associated stress.
Ipek Midi, Aslı Gencel, Hatice Sahin, et al
PCC
Valproate Prescriptions to Reproductive-Age Women in Ambulatory Care
Brief Report

August 22, 2023

With the increased awareness about its teratogenicity, several countries have decreased prescriptions of valproate to reproductive-age women.
Abid Rizvi, Faisal Shaan, Mohammad Reyazuddin
JCP
Nitrous Oxide Reduced Suicidal Ideation in Treatment-Resistant Major Depression
Brief Report

August 16, 2023

In this exploratory analysis, 54% of TRD patients receiving nitrous oxide had a reduction in suicidal ideation, compared with 12% in the placebo group.
Victoria C. de Leon, Arun Kumar, Peter Nagele, et al
PCC
Association of Ulcerative Colitis and Bipolar Disorder
Brief Report

August 10, 2023

This study explored the link between ulcerative colitis and bipolar disorder in an inpatient setting.
Abid Rizvi, Sahar Ashraf, Rupak Desai, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe